Home › Trial NCT01529307
First in Human Trial of TAS266 in Patients With Advanced Solid Tumors
- Trial IDNCT01529307
- StatusTerminated
- PhasePhase 1
- Study typeInterventional
- SponsorNovartis Pharmaceuticals
- Enrollment6
- Start date2012-06
- ConditionsAdvanced Solid Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.